Search Results - "Pokrovsky, Vadim V."

Diversity of Human Immunodeficiency Virus Type 1 Subtype A and CRF03_AB Protease in Eastern Europe: Selection of the V77I Variant and Its Rapid Spread in Injecting Drug User Populations by ROUDINSKII, Nikita I, SUKHANOVA, Anna L, KAZENNOVA, Elena V, WEBER, Jonathan N, POKROVSKY, Vadim V, MIKHAILOVICH, Vladimir M, BOBKOV, Aleksei F

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Cutaneous and visceral leishmaniasis in patients with HIV infection in Russia. Case report by Ermak, Tatiana N., Kravchenko, Aleksei V., Pokrovsky, Vadim V., Andreev, Aleksandr V.

“…The article contains information on the problem of the combined course of HIV infection and leishmaniasis: a number of statistical and overview data in the…”
Get full text

The Russian database of HIV antiretroviral drug resistance by Kireev, Dmitry E., Kirichenko, Alina A., Lopatukhin, Alexey Е., Shlykova, Anastasiia V., Galkin, Nikolai Yu, Saveler, Evgenii V., Glazov, Maxim B., Pokrovsky, Vadim V., Akimkin, Vasily G.

“…The development of sequencing technologies and bioinformatic analysis made it possible to conduct molecular and epidemiological studies, in which nucleotide…”
Get full text

HIV-1 drug resistance among naïve patients in Armenia in 2017–2021 by Osadchaya, Olga A., Kireev, Dmitry E., Saleeva, Daria V., Kirichenko, Alina A., Lapovok, Ilya A., Lopatukhin, Alexey E., Shlykova, Anastasia V., Makhmudova, Leila F., Ladnaya, Natalia N., Hovakimyan, Ermis M., Martoyan, Siranush V., Kazaryan, Hovsep K., Hovsepyan, Tamara V., Sargsiants, Narina K., Pokrovsky, Vadim V.

“…Background. The increased antiretroviral therapy (ART) coverage of patients in the absence of routine drug resistance (DR) tests highlight the importance of…”
Get full text

Human Immunodeficiency Virus Type 1 in Illicit-Drug Solutions Used Intravenously Retains Infectivity by Bobkov, Aleksei F, Selimova, Ludmila M, Khanina, Tatyana A, Zverev, Sergey Y, Pokrovsky, Vadim V, Weber, Jonathan N, Bobkov, Eugene N, Rylkov, Andrey V

“…The stability of the human immunodeficiency virus type 1 (HIV-1) strain IIIB in drug solutions was studied. The data demonstrate that HIV-1 infectivity can be…”
Get full text

Temporal trends in the HIV-1 epidemic in Russia: Predominance of subtype A by Bobkov, Aleksei F., Kazennova, Elena V., Selimova, Ludmila M., Khanina, Tatyana A., Ryabov, Grigory S., Bobkova, Marina R., Sukhanova, Anna L., Kravchenko, Aleksei V., Ladnaya, Natalia N., Weber, Jonathan N., Pokrovsky, Vadim V.

“…During the period 1996–1997, three highly homogeneous variants of HIV‐1 were identified, circulating among injecting drug users (IDUs) in the former Soviet…”
Get full text

An HIV type 1 subtype A outbreak among injecting drug users in Kazakhstan by Bobkov, Aleksei F, Kazennova, Elena V, Sukhanova, Anna L, Bobkova, Marina R, Pokrovsky, Vadim V, Zeman, Victoria V, Kovtunenko, Natalia G, Erasilova, Isidora B

“…Kazakhstan experienced the start of the HIV-1 outbreak among intravenous drug users (IDUs) in 1997. To characterize genetically HIV-1 strains circulating in…”
Get more information

Absence of viral transmission in injecting drug users in Russia by Bobkov, Aleksei F, Samokhvalov, Evgeny I, Lvov, Dmitry K, Bobkova, Marina R, Pokrovsky, Vadim V, Weber, Jonathan N

“…At least 100 000 cases of HIV-1 infection had been identified in Russia by March 2001, more than 90% of which were associated with injected-drug use…”
Get full text

Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: evidence of subtype homogeneity at the main sites of the epidemic by Bobkova, M R, Kazennova, E V, Selimova, L M, Buravtsova, E V, Lister, S, Prilipov, A G, Weber, J N, Pokrovsky, V V, Bobkov, A F

“…The aim of this study was to develop and evaluate a simple V3 peptide-based enzyme immunoassay (PEIA) for large-scale serotyping of HIV-1 specimens derived…”
Get more information

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection by Orkin, Chloe, Arasteh, Keikawus, Górgolas Hernández-Mora, Miguel, Pokrovsky, Vadim, Overton, Edgar T, Girard, Pierre-Marie, Oka, Shinichi, Walmsley, Sharon, Bettacchi, Chris, Brinson, Cynthia, Philibert, Patrick, Lombaard, Johan, St. Clair, Marty, Crauwels, Herta, Ford, Susan L, Patel, Parul, Chounta, Vasiliki, D’Amico, Ronald, Vanveggel, Simon, Dorey, David, Cutrell, Amy, Griffith, Sandy, Margolis, David A, Williams, Peter E, Parys, Wim, Smith, Kimberly Y, Spreen, William R

“…Simplified treatment regimens for HIV-1 may have advantages. In this open-label, randomized, controlled trial, patients with HIV-1 infection who had not…”
Get full text

Human immunodeficiency virus type 1 in illicit-drug solutions used intravenously retains infectivity by BOBKOV, Aleksei F, SELIMOVA, Ludmila M, KHANINA, Tatyana A, ZVEREV, Sergey Y, POKROVSKY, Vadim V, WEBER, Jonathan N, BOBKOV, Eugene N, RYLKOV, Andrey V

Get full text

Temporal trends in the HIV-1 epidemic in Russia: Predominance of subtype A by BOBKOV, Aleksei F, KAZENNOVA, Elena V, POKROVSKY, Vadim V, SELIMOVA, Ludmila M, KHANINA, Tatyana A, RYABOV, Grigory S, BOBKOVA, Marina R, SUKHANOVA, Anna L, KRAVCHENKO, Aleksei V, LADNAYA, Natalia N, WEBER, Jonathan N

Get full text

Low prevalence of HTLV-I/II infection among HIV-1-infected injecting drug users in Russia by Bobkova, M R, Detkova, N V, Buravtsova, E V, Bondarenko, V O, Bobkov, A F, Pokrovsky, V V, Taylor, G P

Get full text

The synthetic peptide from HIV increases functional activity of granulocytes in healthy subjects by Gabrilovich, D I, Kozhich, A T, Rosly, I M, Suvorova, Z K, Ivanov, V S, Moshnikov, S A, Tchikin, L D, Melichov, V I, Pokrovsky, V V

“…The influence of HIV lysate and eight synthetic peptides which are fragments of HIV proteins on the functional activity of polymorphonuclear neutrophils (PMN)…”
Get more information